Overview

Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants

Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about the safety and dosing of rifampin in infants.
Phase:
Phase 1
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Rifampin